Page 2063 - Williams Hematology ( PDFDrive )

2038 Part XII: Hemostasis and Thrombosis <CN>: <ct> PB

39. Choi I, Muta K, Wickrema A, et al: Interferon gamma delays apoptosis of mature ery- 49. Singh AK, Szczech L, Tang KL, et al: Correction of anemia with epoetin alfa in chronic
throid progenitor cells in the absence of erythropoietin. Blood 95:3742, 2000. kidney disease. N Engl J Med 355:2085, 2006.
40. Yu JM, Emmons RV, Hanazono Y, et al: Expression of interferon-gamma by stromal cells inhib- 50. Drüeke TB, Locatelli F, Clyne N, et al: Normalization of hemoglobin level in patients
its murine long-term repopulating hematopoietic stem cell activity. Exp Hematol 27:895, 1999. with chronic kidney disease and anemia. N Engl J Med 355:2071, 2006.
41. Young NS, Scheinberg P, Calado RT: Aplastic anemia. Curr Opin Hematol 15:162, 2008. 51. Rossert J, Levin A, Roger SD, et al: Effect of early correction of anemia on the progres-
42. Tsuji-Takayama K, Tahata H, Harashima A, et al: Interferon-gamma enhances sion of CKD. Am J Kidney Dis 47:738, 2006.
megakaryocyte colony-stimulating activity in murine bone marrow cells. J Interferon 52. Streja E, Kovesdy CP, Greenland S, et al: Erythropoietin, iron depletion, and relative
Cytokine Res 16:701, 1996. thrombocytosis: A possible explanation for hemoglobin-survival paradox in hemodial-
43. Huang Z, Richmond TD, Muntean AG, et al: STAT1 promotes megakaryopoiesis down- ysis. Am J Kidney Dis 52:727, 2008.
stream of GATA-1 in mice. J Clin Invest 117:3890, 2007. 53. Geddis AE, Fox NE, Hitchcock, I: Erythropoietin stimulates thrombopoiesis in the
44. Kulnigg-Dabsch S, Schmid W, Howaldt S, et al. Iron deficiency generates secondary absence of c-Mpl signaling. Blood 112(Suppl 1):2451, 2008.
thrombocytosis and platelet activation in IBD: The randomized, controlled thrombo- 54. Rodríguez-Liñares B, Watson SP: Thrombopoietin potentiates activation of human
VIT trial. Inflamm Bowel Dis 19:1609, 2013. platelets in association with JAK2 and TYK2 phosphorylation. Biochem J 316:93,
45. Akan H, Güven N, Aydogdu I, et al: Thrombopoietic cytokines in patients with iron 1996.
deficiency anemia with or without thrombocytosis. Acta Haematol 103:152, 2000. 55. Brines M, Grasso G, Fiordaliso F, et al: Erythropoietin mediates tissue protection
46. Loo M, Beguin Y: The effect of recombinant human erythropoietin on platelet counts is through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad
strongly modulated by the adequacy of iron supply. Blood 93:3286, 1999. Sci U S A 101:14907, 2004.
47. Bilic E, Bilic E: Amino acid sequence homology of thrombopoietin and erythropoietin 56. Osselaer JC, Jamart J, Scheiff JM: Platelet distribution width for differential diagnosis of
may explain thrombocytosis in children with iron deficiency anemia. J Pediatr Hematol thrombocytosis. Clin Chem 43:1072, 1997.
Oncol 25:675, 2003. 57. Kaushansky K: On the molecular origins of the chronic myeloproliferative disorders: It
48. Geddis AE, Kaushansky K: Cross reactivity between erythropoietin and thrombopoie- all makes sense. Blood 105:4187, 2005.
tin at the level of Mpl does not account for the thrombocytosis seen in iron deficiency. 58. Pikman Y, Lee BH, Mercher T, et al: MPLW515L is a novel somatic activating mutation
J Pediatr Hematol Oncol 25:919, 2003. in myelofibrosis with myeloid metaplasia. PLoS Med 3:e270, 2006.

Kaushansky_chapter 119_p2035-2038.indd 2038 9/18/15 10:26 AM